ArticleJournal of natural medicines2024

Integrating network pharmacology and experimental models to identify notoginsenoside R1 ameliorates atherosclerosis by inhibiting macrophage NLRP3 inflammasome activation.

Jingyue Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.